期刊文献+

双歧杆菌防治极低出生体重儿坏死性小肠结肠炎的作用研究 被引量:4

A research on the effect of bifidobacterium in the field of preventing and curing the NEC of very low birth weight children
下载PDF
导出
摘要 目的:观察应用双歧杆菌预防极低出生体重儿坏死性小肠结肠炎(NEC)的有效性。方法:回顾性分析2005年1月~2008年5月在我院NICU住院治疗的生后存活7 d并且开始胃肠道喂养的极低出生体重儿183例的临床资料。结果:预防组NEC发病率为2.10%(2/95),对照组NEC发生率为11.36%(10/88),两组比较差异有统计学意义(P<0.01)。住院期间预防组每日体质量增加(8.108±2.205)g,对照组为(6.256±2.298)g,两组比较差异有统计学意义(P<0.01)。治疗后7 d两组患儿肠道细菌总数、杆菌、球菌总数及杆球菌比值差异均有统计学意义(P<0.01)。预防组治疗前、治疗后7 d杆球菌比值差异无统计学意义(P>0.05)。治疗前两组患儿大便双歧杆菌数的比较差异均无统计学意义(P>0.05);治疗后7 d两组患儿大便双歧杆菌数的比较差异有统计学意义(P<0.01)。预防组治疗前、治疗后7 d大便双歧杆菌数的比较差异有统计学意义(P<0.01);对照组治疗前、治疗后7 d大便双歧杆菌数的比较差异无统计学意义(P>0.05)。结论:给予极低出生体重儿预防性口服双歧杆菌能够降低NEC发病率,促进其体质量增长。其机制与口服双歧杆菌后促进新生儿肠道正常菌群的定植和优势化、维持肠道正常菌群比率有关。 Objective: To observe the preventing effectiveness of applying bifidobacterium to very low birth weight children with NEC.Methods: The clinical data of 183 patients of NICU hospitalization survival 7 d after birth and fed the gastrointestinal tract of very low birth weight children in our hospital from January 2005 to May 2008 were retrospectively analyzed.Results: From the results,the NEC incidence rate of the preventive group was 2.10%(2/95),while the control group was 11.36%(10/88);the daily weight increase of the preventive group was(8.108±2.205) g,while the control group was(6.256±2.298) g.There were statistical significance in the comparison of both groups(all P〈0.01).In addition,7 days after treatment,the total number of patients′ intestinal bacteria,bacilli,cocci and the comparison value of bacilli and cocci,as well as the comparison of the total number of stool bifidobacterium from patients of both groups and from preventive group′s patients before and after treatment,there were significant differences(P〈0.01).The following conditions do not make any statistical sense(P〉0.05),the comparison value of bacilli and cocci of patients from preventive group before and after treatment;the comparison of both groups′ stool bifidobacterium before treatment;the comparison of the control group’s stool bifidobacterium before and after treatment.Conclusion: By taking oral feeding of preventive bifidobacterium,the NEC incidence ratio of very low birth weight children will be reduced,because it can promote the colonization and optimazition of the newborn infants′ normal intestinal flora,and also maintain the ratio of normal intestinal flora.Furthermore,it can help increase weight of the very low birth weight children by this means
作者 黄柏枝 刘仿
出处 《中国医药导报》 CAS 2011年第11期35-36,39,共3页 China Medical Herald
基金 广东省东莞市科技计划项目(No.200610515025062)
关键词 坏死性小肠结肠炎 极低出生体重儿 微生态制剂 双歧杆菌 NEC Very low birth weight children Probiotics Bifidobacterium
  • 相关文献

参考文献10

  • 1李德渊,母得志.新生儿坏死性小肠结肠炎的研究进展[J].国际儿科学杂志,2007,34(6):444-447. 被引量:10
  • 2Yosl CC. Neonatal necrotizing enterocolitis: diagnosis, management, and pathogenesis [J]. J Infus Nurs,2005,28(2):13-14.
  • 3黎永学,姜明杰,张莉滟,张德纯.一种改良大便双歧杆菌计数方法[J].中国微生态学杂志,2002,14(3):177-178. 被引量:12
  • 4Taeuseh HW,Balard RA.艾弗里新生儿病学(影印版)[M].7版.北京:科学出版社.2001:578-582.
  • 5宋朝敏,王红,吴斌.益生菌与新生儿坏死性小肠结肠炎[J].中国微生态学杂志,2005,17(6):479-480. 被引量:19
  • 6Ito Y, Doelle SM, Clark JA, et al. Intestinal microcirculatory dysfunction during the development of experimental neerotizing enterocolitis [J]. Pediatr Res,2007,62(2): 180-184.
  • 7Kitajima H, Sumida Y, Tanaka R, et al. Early administration of bifidobacterium breve to pretern infants, randomized controlled trail [J]. Arch Dis Child Fetal Neonatal ED,1997,76(2):101-107.
  • 8Grave GD, Nelson SA, Walker WA, et al. New therapies and preventive approaches for neerotizing enterocolitis: report of a research planning workshop [J]. Pediatr Res,2007,62(4):510-514.
  • 9Ganz T. Defensins and other antimicrobial peptides: a historical perspective and an update [J]. Comb Chem High Throughput Screen, 2005,8(1):209-217.
  • 10Catherine HJ, Jeffrey US, Henri FR, et al. Understanding the susceptibility of the premature Infant to necrotizing enterocolitis (NEC) [J]. Pediatr Res,2008,63(2):117-123.

二级参考文献37

  • 1Kafetzis DA,Skevaki C,Costalos C.Neonatal necrotizing enterotizing;an overview[J].Current Opinion in Infect Dis,2003,16(4):349-355.
  • 2Butel MJ,Roland N,Hibert A et al.Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of Bifidobacteria[J].J Med Microbiol,1998,47:391-399.
  • 3Srinivas S,Kapoor SS,Bamford PD,et al.Role of bacteria and immunosuppressive agent in a weanling rabbit lleall loop model of necrotizing enterocolitis[J].Pediatr Res,1999,45(4):part 2 of 2:227A.
  • 4Caplan MS,Miller-Catchhpole R,Kaup S,et al.Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model[J].Gastroenterol,1999,117:577-583.
  • 5Hoyos AB.Reduced incidence of necrotizingenterocolitis associated with enteral administration of Lactobacillus acidophillus and Bifidobacterium infantis to neonates in an intensive care unit[J].Int J Infect Dis,1999,3:197-202.
  • 6Lin HC,Su BH,Chen AC,et al.Oral probiotic reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infant[J].Pediatr,2005,115(1):1-4.
  • 7Dani C,Biadaioli R,Bertini G,et al.Probiotics feeding in prevention of urinary tract infection,bacterial sepsis and necrotizing enterocolitis in preterm infants a prospective double-blind study[J].Biol of the Neonate,2002,82:103-108.
  • 8Bell ED.Preventing necrotizing enterocolitis;what works and how safe?[J].Pediatr,2005,115:1.
  • 9Agarwal R,Sharma N,Chaudhry R,et al.Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates[J].J Pediatr Gastroenterol Nutr,2003,36(3):S397-402.
  • 10Kitajima H,Sumida Y,Tanaka R,et al.Early administration of Bifidobacterium breve to preterm infants;randomized controlled trail[J].Arch Dis Child Fetal Neonatal Ed,1997.76:101-107.

共引文献38

同被引文献34

  • 1魏克伦,杨于嘉,姚裕家,杜立中,王庆红.中国住院新生儿流行病学调查[J].中国当代儿科杂志,2009,11(1):15-20. 被引量:211
  • 2宋朝敏,王红,吴斌.益生菌与新生儿坏死性小肠结肠炎[J].中国微生态学杂志,2005,17(6):479-480. 被引量:19
  • 3De Vrese M, Schrezenmeir J. Bifidobacterium, prebiotics, and synbiotics[J]. Food Biotechnology, 2008,111(1) : 1-66.
  • 4Henry MC, Moss LR. Neerotizing enteroeolitis[J]. Annu Rev Med,2009,60(1) : 111-124.
  • 5Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis[J]. Semin Perinato, 2008,32 (2) : 127-137.
  • 6Jarvis MA, Borton JA,Keech AM, et al. Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation [J]. Journal of Virology, 2006, 80 ( 11 ):5588-5589.
  • 7Zwerina J,Redlich K,Polzer K,et al. TNF- induced structural joint damage is mediated by IL-1 [J]. Proceedings of the National Academy of Sciences, 2007, 104 ( 28 ):11742-11747.
  • 8Montag C, Wagner J, Gruska I, et al. Human cytomegalovirus blocks tumor necrosis factor-alpha and Interleukin-lbetamediated NF-kappaB signaling[J]. Journal of Virology, 2006,80(23) : 11686-11689.
  • 9Baud V,Karin M. Signal transduction by tumor necrosis factor and its relatives[J]. Trends in Cell Biology, 2001,11 (9) :372-377.
  • 10Halpern MD,Clark JA,Saunders TA,et al. Reduction of experimental neerotizing enteroeolitis with anti-TNF-a alpha [J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2006,290 (4) : 757-764.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部